Publication | Closed Access

Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway

C-src ActivityMedicineApoptosisCell DeathAnti-cancer AgentPharmacologyCell BiologyErk1/2 PathwayOxidative Stress